UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060577
Receipt number R000069288
Scientific Title Development and Validation of a Cardiovascular High-Risk Identification Algorithm Combining BMI and Body Muscle-to-Fat Ratio (BMFR) in Patients with Diabetes Mellitus
Date of disclosure of the study information 2026/03/01
Last modified on 2026/02/04 12:48:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Combined Use of BMI and Body Muscle-to-Fat Ratio (BMFR) for Identifying High-Risk Patients with Diabetes Mellitus

Acronym

BMI-BMFR Risk Study

Scientific Title

Development and Validation of a Cardiovascular High-Risk Identification Algorithm Combining BMI and Body Muscle-to-Fat Ratio (BMFR) in Patients with Diabetes Mellitus

Scientific Title:Acronym

BMI-BMFR Risk Study

Region

Japan


Condition

Condition

Type 2 Diabetes Mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine whether the combination of BMI and BMFR can identify cardiovascular high risk patients who are not detected by BMI alone, and to develop a novel algorithm based on the combination of BMI and BMFR for risk stratification

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Presence of cardiovascular disease high risk status defined as 2 or more of the following conditions: hypertension, dyslipidemia, fatty liver, chronic kidney disease, or hyperuricemia, and its identification based on BMFR classification

Key secondary outcomes

1. Prevalence of high risk stratified by BMI and BMFR, 2. Association between four groups (normal, hidden obesity, healthy obesity, metabolic obesity) and CVD risk, 3. Odds ratios estimated by logistic regression analysis


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with type 2 diabetes mellitus treated at our clinic
Aged 18 years or older
Those who underwent body composition assessment enabling measurement of skeletal muscle mass and fat mass
Individuals in whom BMI and BMFR can be calculated
Patients whose medical records allow assessment of hypertension, dyslipidemia, fatty liver, chronic kidney disease, and hyperuricemia

Key exclusion criteria

Patients with missing body composition data
Individuals in whom body composition measurement is contraindicated
Patients with active malignancy
Those with marked fluid imbalance due to severe heart failure, liver failure, or renal failure
Patients judged inappropriate for inclusion by the investigator

Target sample size

118


Research contact person

Name of lead principal investigator

1st name Noboru
Middle name
Last name Kurinami

Organization

Jinnouchi Hospital

Division name

Internal Medicine

Zip code

862-0976

Address

6-2-3 Kuhonji, Chuo-ku, Kumamoto City, Kumamoto

TEL

0963630011

Email

kurinami@jinnouchi.or.jp


Public contact

Name of contact person

1st name NOBORU
Middle name
Last name KURINAMI

Organization

Jinnouchi Hospital

Division name

Internal Medicine

Zip code

862-0976

Address

6-2-3 Kuhonji, Chuo-ku, Kumamoto City, Kumamoto

TEL

0963630011

Homepage URL


Email

kurinami@jinnouchi.or.jp


Sponsor or person

Institute

Jinnouchi Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Jinnouchi

Address

6-2-3 Kuhonji, Chuo-ku, Kumamoto City, Kumamoto

Tel

0963630011

Email

kurinami@jinnouchi.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 02 Month 01 Day

Date of IRB


Anticipated trial start date

2026 Year 03 Month 01 Day

Last follow-up date

2027 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is an observational study without any intervention, based on a cross-sectional analysis of clinical information and body composition data obtained in routine clinical practice. The study was designed on the basis of our previous report (J Clin Med Res. 2021;13(7):387-391) to evaluate the validity of a novel algorithm combining BMI and Body Muscle-to-Fat Ratio (BMFR) for identifying cardiovascular disease (CVD) high-risk patients. Data are collected from medical records and bioelectrical impedance analysis, and no additional invasive procedures are performed.


Management information

Registered date

2026 Year 02 Month 04 Day

Last modified on

2026 Year 02 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069288